Selected Publications

Park J, Levin MG, Zhang D, Reza N, Mead JO, Carruth ED, Kelly MA, Winters A, Kripke CM, Judy RL, Damrauer SM, Owens AT, Bastarache L, Verma A, Kinnamon DD, Hershberger RE, Ritchie MD, Rader DJ.: Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3. JAMA Cardiol 9: 1124-1133, Dec 2024.

Abramowitz SA, Boulier K, Keat K, Cardone KM, Shivakumar M, DePaolo J, Judy R, Bermudez F, Mimouni N, Neylan C, Kim D, Rader DJ, Ritchie MD, Voight BF, Pasaniuc B, Levin MG, Damrauer SM; Penn Medicine BioBank.: Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores. JAMA Nov 2024.

Walker V, Sanderson E, Levin MG, Damraurer SM, Feeney T, Davies NM.: Reading and conducting instrumental variable studies: guide, glossary, and checklist. BMJ 387: e078093, Oct 2024.

Abramowitz SA, Boulier K, Keat K, Cardone KM, Shivakumar M, DePaolo J, Judy R, Kim D, Rader DJ, Ritchie MD, Voight BF, Pasaniuc B, Levin MG, Damrauer SM.: Population Performance and Individual Agreement of Coronary Artery Disease Polygenic Risk Scores. medRxiv Oct 2024.

Zhang DY, Levin MG, Duda JT, Landry LG, Witschey WR, Damrauer SM, Ritchie MD, Rader DJ.: Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles. JCI Insight 9: e181238, Oct 2024.

Roberson JL, Farzaneh C, Neylan CJ, Judy R, Walker V, Damrauer SM, Levin MG, Maguire LH; Regeneron Genetics Center; Penn Medicine BioBank.: Genome-Wide Association Study Identifies Genes for Hair Growth and Patterning are Associated With Pilonidal Disease. Dis Colon Rectum 67: 1149-1157, Sep 2024.

Clarke SL, Huang RDL, Hilliard AT, Levin MG, Sharma D, Thomson B, Lynch J, Tsao PS, Gaziano JM, Assimes TL; VA Million Veteran Program.: Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol. Eur J Prev Cardiol Aug 2024.

Moore A, Venkatesh R, Levin MG, Damrauer SM, Reza N, Cappola TP, Ritchie MD.: Connecting intermediate phenotypes to disease using multi-omics in heart failure. medRxiv Aug 2024.

Fanaroff AC, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J, Levin MG, Damrauer SM, Giri JS, Chokshi NP, Jackson BM, Patel MS.: Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study. Am Heart J 270(5): 95-102, Apr 2024 Notes: doi: 10.1161/JAHA.123.031154. Epub 2024 Feb 29.

Dib MJ*, Levin MG*, Zhao L, Diab A, Wang Z, Ebert C, Salman O, Azzo JD, Gan S, Zamani P, Cohen JB, Gill D, Burgess S, Zagkos L, van Empel V, Richards AM, Doughty R, Rietzschel ER, Kammerhoff K, Kvikstad E, Maranville J, Schafer P, Seiffert DA, Ramirez-Valle F, Gordon DA, Chang CP, Javaheri A, Mann DL, Cappola TP, Chirinos JA.: Proteomic Associations of Adverse Outcomes in Human Heart Failure. J Am Heart Assoc 13(5): e031154, Mar 2024 Notes: doi: 10.1161/JAHA.123.031154. Epub 2024 Feb 29.